AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36007302 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor PM2.5 concentrations during pregnancy
Number of subjects: 540
Study 33682693 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping with tension (KTT)
Number of subjects: 60
Study 33682693 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping no tension (KTNT)
Number of subjects: 60
Study 33682693 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 60
Study 33682693 — intervention group
Group type: EXPERIMENTAL
Intervention: KTT and KTNT
Number of subjects: 60
Study 33090921 — intervention group
Group type: EXPERIMENTAL
Intervention: PRC-063 (methylphenidate), 25 mg/day titrated to maximum 85 mg/day
Number of subjects: 147
Study 33090921 — intervention group
Group type: EXPERIMENTAL
Intervention: PRC-063 (methylphenidate)
Number of subjects: 147
Study 33090921 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 35412603 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi‐tetanus toxoid TCV
Number of subjects: 61654
Study 35412603 — intervention group
Group type: EXPERIMENTAL
Intervention: Better WASH households
Number of subjects: 61654
Study 35412603 — intervention group
Group type: EXPERIMENTAL
Intervention: Better WASH in TCV clusters
Number of subjects: 61654
Study 35412603 — intervention group
Group type: COMPARATOR
Intervention: Japanese Encephalitis (JE) vaccine
Number of subjects: 61654
Study 33118456 — intervention group
Group type: EXPERIMENTAL
Intervention: Potentially identifiable interview
Number of subjects: 0
Study 33118456 — intervention group
Group type: COMPARATOR
Intervention: Anonymous survey
Number of subjects: 0
Study 32273094 — intervention group
Group type: EXPERIMENTAL
Intervention: COMBO stent
Number of subjects: 862
Study 32273094 — intervention group
Group type: COMPARATOR
Intervention: Orsiro stent
Number of subjects: 862
Study 35333027 — intervention group
Group type: EXPERIMENTAL
Intervention: FIVE program (neuromuscular warm-up) performed in addition to regular futsal training, three times per week for 6 weeks.
Number of subjects: 95
Study 35333027 — intervention group
Group type: COMPARATOR
Intervention: Regular futsal training only (Control group).
Number of subjects: 95
Study 35333027 — intervention group
Group type: EXPERIMENTAL
Intervention: FIVE program (experimental group).
Number of subjects: 95
Study 34357593 — intervention group
Group type: EXPERIMENTAL
Intervention: BBT‐CI intervention
Number of subjects: 139
Study 34357593 — intervention group
Group type: COMPARATOR
Intervention: HEAL control intervention
Number of subjects: 139
Study 35488487 — intervention group
Group type: EXPERIMENTAL
Intervention: Brand metoprolol ER tablets
Number of subjects: 36
Study 35488487 — intervention group
Group type: COMPARATOR
Intervention: Drug 1 (generic metoprolol ER)
Number of subjects: 36
Study 35488487 — intervention group
Group type: COMPARATOR
Intervention: Drug 2 (generic metoprolol ER)
Number of subjects: 36
Study 33755713 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2618960 (0.6 mg/kg)
Number of subjects: 11
Study 33755713 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2618960 (2.0 mg/kg)
Number of subjects: 11
Study 33755713 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2618960
Number of subjects: 11
Study 35595658 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab in addition to anthracycline taxane-based neoadjuvant therapy
Number of subjects: 82
Study 32710212 — intervention group
Group type: EXPERIMENTAL
Intervention: PTE-RV
Number of subjects: 84
Study 37103755 — intervention group
Group type: EXPERIMENTAL
Intervention: Ravulizumab
Number of subjects: 161
Study 32933342 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic medical record-based methods
Number of subjects: 294
Study 32933342 — intervention group
Group type: COMPARATOR
Intervention: Non-electronic medical record-based methods
Number of subjects: 294
Study 32933342 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient portal messaging
Number of subjects: 294
Study 32933342 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct mail to non-active patient portal
Number of subjects: 294
Study 35788493 — intervention group
Group type: EXPERIMENTAL
Intervention: Leflunomide
Number of subjects: 270
Study 35788493 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine
Number of subjects: 270
Study 34410254 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioception training twice a week for eight weeks along with diabetes awareness lectures once a week
Number of subjects: 38
Study 34410254 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving only diabetes awareness lectures
Number of subjects: 38
Study 34410254 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioception training
Number of subjects: 38
Study 36095058 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy for physical activity with perceived facilitators (24 items retained)
Number of subjects: 0
Study 36095058 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy to overcome barriers (28 items retained)
Number of subjects: 0
Study 34922527 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized and detailed multivariate method based on Caries Care International 4D guidelines
Number of subjects: 2
Study 34922527 — intervention group
Group type: COMPARATOR
Intervention: Simplified method based on caries experience evaluation using the DMFT/dmft index
Number of subjects: 2
Study 32060017 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention (dietary weight loss)
Number of subjects: 39
Study 32060017 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic control (NDC) group
Number of subjects: 39
Study 35190406 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells (MSCs) transfusion on days 0 and 7
Number of subjects: 100
Study 35190406 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline) on days 0 and 7
Number of subjects: 100
Study 33725471 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 0
Study 33725471 — intervention group
Group type: COMPARATOR
Intervention: Interactive education intervention
Number of subjects: 0
Study 32650988 — intervention group
Group type: EXPERIMENTAL
Intervention: cfDNA extraction using QIAamp Circulating Nucleic Acid Extraction Kit (Qiagen)
Number of subjects: 52
Study 32650988 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncomine Breast cfDNA Assay (A31183) and custom Ampliseq Ion Torrent panel targeting breast cancer-related genes
Number of subjects: 52
Study 32207209 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR+ (Biofermin-R) with VPZ-based therapy
Number of subjects: 0
Study 32207209 — intervention group
Group type: COMPARATOR
Intervention: BFR- (no Biofermin-R) with VPZ-based therapy
Number of subjects: 0
Study 34861776 — intervention group
Group type: EXPERIMENTAL
Intervention: UMPCNL in FFMS position
Number of subjects: 55
Study 34861776 — intervention group
Group type: COMPARATOR
Intervention: UMPCNL in prone position
Number of subjects: 55
Study 34003690 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose
Number of subjects: 3014
Study 34003690 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3014
Study 35348950 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 119
Study 35348950 — intervention group
Group type: COMPARATOR
Intervention: No letrozole (Control)
Number of subjects: 119
Study 34479646 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordinated care program (SOFIA model)
Number of subjects: 180
Study 34479646 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 180
Study 33849123 — intervention group
Group type: EXPERIMENTAL
Intervention: Infection prevention group
Number of subjects: 128
Study 33849123 — intervention group
Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 128
Study 35060833 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk score based on identified factors
Number of subjects: 1313
Study 34505186 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol and delta‐9‐tetrahydrocannabinol
Number of subjects: 3
Study 33407264 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin bilateral medial rectus injections
Number of subjects: 60
Study 33407264 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 60
Study 32762424 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-persuasion task (participants generate own arguments or arguments they think the close other would give)
Number of subjects: 987
Study 32762424 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct persuasion task (participants read given arguments or imagine arguments from the close other)
Number of subjects: 987
Study 32762424 — intervention group
Group type: EXPERIMENTAL
Intervention: Thinking of a close other
Number of subjects: 987
Study 34821127 — intervention group
Group type: EXPERIMENTAL
Intervention: Majoon-e-Seer Alvi Khan (MSAK) for 60 days along with lifestyle modification
Number of subjects: 40
Study 34821127 — intervention group
Group type: COMPARATOR
Intervention: Tablet Atorvastatin for 60 days along with lifestyle modification
Number of subjects: 40
Study 35869710 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic Paravertebral Block (TPVB) before general anesthesia
Number of subjects: 80
Study 35869710 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia
Number of subjects: 80
Study 36402600 — intervention group
Group type: EXPERIMENTAL
Intervention: Animation
Number of subjects: 183
Study 36402600 — intervention group
Group type: EXPERIMENTAL
Intervention: Music
Number of subjects: 183
Study 36402600 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 183
Study 33864887 — intervention group
Group type: EXPERIMENTAL
Intervention: Papacarie for 60s
Number of subjects: 40
Study 33864887 — intervention group
Group type: EXPERIMENTAL
Intervention: Carisolv for 60s
Number of subjects: 40
Study 33864887 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% NaOCl for 15s
Number of subjects: 40
Study 33864887 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 40
Study 33802311 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Mind program (eMH intervention) for eight weeks
Number of subjects: 150
Study 33802311 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (no intervention during the eight weeks)
Number of subjects: 150
Study 32930387 — intervention group
Group type: EXPERIMENTAL
Intervention: mFOLFOX6 + nintedanib (F + N) (2 × 200 mg p.o./d, d1‐d14)
Number of subjects: 53
Study 32930387 — intervention group
Group type: COMPARATOR
Intervention: mFOLFOX6 + placebo (F + P)
Number of subjects: 53
Study 32930387 — intervention group
Group type: EXPERIMENTAL
Intervention: mFOLFOX6 + nintedanib (F + N)
Number of subjects: 53
Study 36343061 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) model using one knee magnetic resonance image
Number of subjects: 164
Study 32221989 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT + ICT
Number of subjects: 60
Study 32221989 — intervention group
Group type: COMPARATOR
Intervention: CBT + sham training
Number of subjects: 60
Study 34776351 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief focused ultrasound of ventricular filling and function, lung, and peritoneal spaces, performed before surgery.
Number of subjects: 660
Study 33185570 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral hand-off
Number of subjects: 41
Study 33185570 — intervention group
Group type: COMPARATOR
Intervention: Rude hand-off
Number of subjects: 41
Study 33185570 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral hand-off (Residents)
Number of subjects: 41
Study 33185570 — intervention group
Group type: COMPARATOR
Intervention: Rude hand-off (Residents)
Number of subjects: 41
Study 33185570 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience (Residents)
Number of subjects: 41
Study 33185570 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience (Fellows)
Number of subjects: 41
Study 33185570 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience (Attendings)
Number of subjects: 41
Study 33185570 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience
Number of subjects: 41
Study 33883459 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual airway cognitive aid
Number of subjects: 40
Study 33883459 — intervention group
Group type: COMPARATOR
Intervention: Control group (no visual airway cognitive aid)
Number of subjects: 40
Study 34879921 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermia exposure programme (WBPH)
Number of subjects: 20
Study 34879921 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure (SHAM)
Number of subjects: 20
Study 33080294 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-based mindfulness-based stress reduction course (IMMI)
Number of subjects: 64
Study 33080294 — intervention group
Group type: COMPARATOR
Intervention: internet-based health and wellness education course
Number of subjects: 64
Study 33080294 — intervention group
Group type: COMPARATOR
Intervention: waitlist control condition
Number of subjects: 64
Study 37610062 — intervention group
Group type: COMPARATOR
Intervention: Imeglimin monotherapy at 1,000 mg twice daily
Number of subjects: 1655
Study 37610062 — intervention group
Group type: COMPARATOR
Intervention: Imeglimin monotherapy at 1,500 mg
Number of subjects: 1655
Study 37610062 — intervention group
Group type: COMPARATOR
Intervention: Imeglimin monotherapy at 2,000 mg
Number of subjects: 1655
Study 37610062 — intervention group
Group type: COMPARATOR
Intervention: Imeglimin adjunctive therapy at 1,000 mg
Number of subjects: 1655
Study 37610062 — intervention group
Group type: COMPARATOR
Intervention: Imeglimin adjunctive therapy at 1,500 mg
Number of subjects: 1655
Study 37610062 — intervention group
Group type: EXPERIMENTAL
Intervention: Imeglimin (monotherapy and adjunctive therapy)
Number of subjects: 1655
Study 37610062 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1655
Study 32900519 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg trans-resveratrol twice-daily for 12 months
Number of subjects: 125
Study 32900519 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 32739494 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg aspirin
Number of subjects: 19114
Study 32739494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19114
Study 36054038 — intervention group
Group type: EXPERIMENTAL
Intervention: Edaravone treatment after placebo
Number of subjects: 146
Study 36054038 — intervention group
Group type: EXPERIMENTAL
Intervention: Edaravone treatment
Number of subjects: 146
Study 36054038 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 146
Study 32077301 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-weighing-only programs
Number of subjects: 498
Study 32077301 — intervention group
Group type: EXPERIMENTAL
Intervention: Programs with financial incentives
Number of subjects: 498
Study 34823128 — intervention group
Group type: EXPERIMENTAL
Intervention: Influence-gain nudge
Number of subjects: 1595
Study 34823128 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison nudge
Number of subjects: 1595
Study 34823128 — intervention group
Group type: EXPERIMENTAL
Intervention: Influence-loss nudge
Number of subjects: 1595
Study 34823128 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1595
Study 34085363 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood group A
Number of subjects: 72
Study 34085363 — intervention group
Group type: COMPARATOR
Intervention: Blood group O
Number of subjects: 72
Study 34085363 — intervention group
Group type: COMPARATOR
Intervention: Blood group A vs O
Number of subjects: 72
Study 33974574 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased compression factor (1.75 D)
Number of subjects: 44
Study 33974574 — intervention group
Group type: COMPARATOR
Intervention: Conventional compression factor (0.75 D)
Number of subjects: 44
Study 33974574 — intervention group
Group type: EXPERIMENTAL
Intervention: Both compression factors
Number of subjects: 44
Study 34773302 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined photodynamic therapy (combPDT)
Number of subjects: 51
Study 34773302 — intervention group
Group type: COMPARATOR
Intervention: Conventional photodynamic therapy (cPDT)
Number of subjects: 51
Study 33693737 — intervention group
Group type: EXPERIMENTAL
Intervention: β-Lactoglobulin (BLG)
Number of subjects: 9
Study 33693737 — intervention group
Group type: COMPARATOR
Intervention: Whey Protein (WHE)
Number of subjects: 9
Study 32812363 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous spinal direct current stimulation (tsDCS) at 2.5 mA for 10 min
Number of subjects: 41
Study 32812363 — intervention group
Group type: COMPARATOR
Intervention: Sham transcutaneous spinal direct current stimulation (sham tsDCS)
Number of subjects: 41
Study 32812363 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous spinal direct current stimulation (tsDCS)
Number of subjects: 41
Study 35471471 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose Lingguizhugan Decoction (LGZG)
Number of subjects: 243
Study 35471471 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose Lingguizhugan Decoction (LGZG)
Number of subjects: 243
Study 35471471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study 34939395 — intervention group
Group type: EXPERIMENTAL
Intervention: Shumian capsule
Number of subjects: 200
Study 34939395 — intervention group
Group type: COMPARATOR
Intervention: Shumian capsule simulator (control)
Number of subjects: 200
Study 34963728 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocolized weaning using pressure support spontaneous breathing trial (PS SBT) for 2 hours duration followed by a T-piece trial before extubation.
Number of subjects: 80
Study 34963728 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocolized weaning using PS SBT
Number of subjects: 80
Study 34963728 — intervention group
Group type: COMPARATOR
Intervention: Conventional weaning with synchronized intermittent mandatory ventilation mode and a T-piece trial before extubation.
Number of subjects: 80
Study 34963728 — intervention group
Group type: COMPARATOR
Intervention: Conventional weaning
Number of subjects: 80
Study 34963728 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (reintubated patients)
Number of subjects: 80
Study 32212275 — intervention group
Group type: EXPERIMENTAL
Intervention: TransCon PTH (3.5 to 124 μg PTH(1‐34) for SAD; 3.5 to 24 μg PTH(1‐34)/day for MAD)
Number of subjects: 10
Study 32212275 — intervention group
Group type: EXPERIMENTAL
Intervention: TransCon PTH
Number of subjects: 10
Study 32212275 — intervention group
Group type: EXPERIMENTAL
Intervention: TransCon PTH (administered daily for 10 days)
Number of subjects: 10
Study 35353292 — intervention group
Group type: EXPERIMENTAL
Intervention: continuous Theta Burst Stimulation (cTBS)
Number of subjects: 35
Study 35353292 — intervention group
Group type: COMPARATOR
Intervention: placebo stimulation
Number of subjects: 35
Study 34098302 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time video counselling
Number of subjects: 655
Study 34098302 — intervention group
Group type: COMPARATOR
Intervention: Telephone counselling
Number of subjects: 655
Study 34098302 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention control (written materials)
Number of subjects: 655
Study 33168489 — intervention group
Group type: COMPARATOR
Intervention: Adper Single Bond Universal (Etch‐and‐rinse mode)/Filtek Z250 with W-water (control)
Number of subjects: 90
Study 33168489 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond Universal (Etch‐and‐rinse mode)/Filtek Z250 with CHX-2% digluconate chlorhexidine
Number of subjects: 90
Study 33168489 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond Universal (Etch‐and‐rinse mode)/Filtek Z250 with E64-5 μM E64
Number of subjects: 90
Study 33168489 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond Universal (Etch‐and‐rinse mode)/Filtek Z250 with ACD-W
Number of subjects: 90
Study 33168489 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond Universal (Etch‐and‐rinse mode)/Filtek Z250 with ERO-W
Number of subjects: 90
Study 33168489 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond Universal (Etch‐and‐rinse mode)/Filtek Z250 with ACD-CHX
Number of subjects: 90
Study 33168489 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond Universal (Etch‐and‐rinse mode)/Filtek Z250 with ACD-E64
Number of subjects: 90
Study 33168489 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond Universal (Etch‐and‐rinse mode)/Filtek Z250 with ERO-CHX
Number of subjects: 90
Study 33168489 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond Universal (Etch‐and‐rinse mode)/Filtek Z250 with ERO-E64
Number of subjects: 90
Study 32524330 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive assessment of familial breast cancer risk using a validated postal family history questionnaire and decision support software.
Number of subjects: 7012
Study 32524330 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral to specialists for further assessment.
Number of subjects: 7012
Study 32524330 — intervention group
Group type: COMPARATOR
Intervention: Usual care without proactive assessment.
Number of subjects: 7012
Study 36457200 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymicrobial probiotic (PMP group)
Number of subjects: 116
Study 36457200 — intervention group
Group type: COMPARATOR
Intervention: Mono-strain probiotic (MSP group)
Number of subjects: 116
Study 36457200 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 116
Study 32885276 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine (20 mg orally every 8 hours)
Number of subjects: 136
Study 32885276 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral every 8 hours)
Number of subjects: 136
Study 32885276 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine (20 mg)
Number of subjects: 136
Study 33065954 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (54 to 64 U)
Number of subjects: 139
Study 36497618 — intervention group
Group type: EXPERIMENTAL
Intervention: SHIFT intervention for drivers with obesity (BMI ≥ 30 kg/m2)
Number of subjects: 244
Study 36497618 — intervention group
Group type: COMPARATOR
Intervention: Control group for drivers with obesity (BMI ≥ 30 kg/m2)
Number of subjects: 244